Skip to main content
Top
Published in: Cancer Causes & Control 2/2008

01-03-2008 | Original Paper

Doubling of testicular cancer incidence rate over the last 20 years in southern France

Authors: Marie Walschaerts, Eric Huyghe, Audrey Muller, Jean-Marc Bachaud, Louis Bujan, Patrick Thonneau

Published in: Cancer Causes & Control | Issue 2/2008

Login to get access

Abstract

In recent decades, testicular cancer incidence has considerably increased in a majority of industrialized countries. In France, short reports suggested that the testicular cancer incidence rate has also risen, especially in north-eastern regions. In Europe, geographical variation of incidence rates has been observed in Baltic countries and a clear birth cohort effect has been revealed. This study aimed to assess temporal trends in testicular cancer incidence in southern France. We examined incidence rates over a 20-year time period in a series of 506 consecutive cases of testicular cancer recorded from 1980 to 1999 in the Midi-Pyrenees region of France. Age, calendar period, and birth cohort effects were examined simultaneously using Poisson regression models. Our analysis found a significant rise in the overall incidence rate of testicular germ cell tumors from 1.27 to 3.04 per 100,000 between 1980–1984 and 1995–1999, an annual increase of 5.70%. These results, the first obtained in a large series in southern Europe, show a twofold increase in incidence rate of testicular cancer in the Midi-Pyrenees region, which is very similar to that observed in all European countries, more or less doubling in the last 20 years. Interestingly, this major jump and the apparent testicular cancer gradient between northern and southern Europe suggest considerable geographical heterogeneity in incidence, but low geographical variation in temporal trends.
Literature
2.
go back to reference Parkin D, Whelan S, Ferlay J, Raymond L, Young J (1997) Cancer incidence in five continents. IARC Scientific Publications, Lyon Parkin D, Whelan S, Ferlay J, Raymond L, Young J (1997) Cancer incidence in five continents. IARC Scientific Publications, Lyon
3.
go back to reference Huyghe E, Matsuda T, Thonneau P (2003) Increasing incidence of testicular cancer worldwide: a review. J Urol 170:5–11PubMedCrossRef Huyghe E, Matsuda T, Thonneau P (2003) Increasing incidence of testicular cancer worldwide: a review. J Urol 170:5–11PubMedCrossRef
4.
go back to reference Richiardi L, Bellocco R, Adami HO et al (2004) Testicular cancer incidence in eight northern European countries: secular and recent trends. Cancer Epidemiol Biomarkers Prev 13:2157–2166PubMed Richiardi L, Bellocco R, Adami HO et al (2004) Testicular cancer incidence in eight northern European countries: secular and recent trends. Cancer Epidemiol Biomarkers Prev 13:2157–2166PubMed
5.
go back to reference McGlynn KA, Devesa SS, Sigurdson AJ et al (2003) Trends in the incidence of testicular germ cell tumors in the United States. Cancer 97:63–70PubMedCrossRef McGlynn KA, Devesa SS, Sigurdson AJ et al (2003) Trends in the incidence of testicular germ cell tumors in the United States. Cancer 97:63–70PubMedCrossRef
6.
go back to reference McGlynn KA, Devesa SS, Graubard BI, Castle PE (2005) Increasing incidence of testicular germ cell tumors among black men in the United States. J Clin Oncol 23:5757–5761PubMedCrossRef McGlynn KA, Devesa SS, Graubard BI, Castle PE (2005) Increasing incidence of testicular germ cell tumors among black men in the United States. J Clin Oncol 23:5757–5761PubMedCrossRef
7.
go back to reference Bray F, Richiardi L, Ekbom A et al (2006) Trends in testicular cancer incidence and mortality in 22 European countries: continuing increases in incidence and declines in mortality. Int J Cancer 118:3099–3111PubMedCrossRef Bray F, Richiardi L, Ekbom A et al (2006) Trends in testicular cancer incidence and mortality in 22 European countries: continuing increases in incidence and declines in mortality. Int J Cancer 118:3099–3111PubMedCrossRef
8.
go back to reference Toledano MB, Jarup L, Best N, Wakefield J, Elliott P (2001) Spatial variation and temporal trends of testicular cancer in Great Britain. Br J Cancer 84:1482–1487PubMedCrossRef Toledano MB, Jarup L, Best N, Wakefield J, Elliott P (2001) Spatial variation and temporal trends of testicular cancer in Great Britain. Br J Cancer 84:1482–1487PubMedCrossRef
9.
go back to reference Hedelin G, Remontet L (2002) Evolution du cancer du testicule en France. Andrologie 12:269–273CrossRef Hedelin G, Remontet L (2002) Evolution du cancer du testicule en France. Andrologie 12:269–273CrossRef
10.
go back to reference Remontet L, Esteve J, Bouvier AM et al (2003) Cancer incidence and mortality in France over the period 1978–2000. Rev Epidemiol Sante Publique 51:3–30PubMed Remontet L, Esteve J, Bouvier AM et al (2003) Cancer incidence and mortality in France over the period 1978–2000. Rev Epidemiol Sante Publique 51:3–30PubMed
11.
go back to reference Ekbom A, Richiardi L, Akre O, Montgomery SM, Sparen P (2003) Age at immigration and duration of stay in relation to risk for testicular cancer among Finnish immigrants in Sweden. J Natl Cancer Inst 95:1238–1240PubMedCrossRef Ekbom A, Richiardi L, Akre O, Montgomery SM, Sparen P (2003) Age at immigration and duration of stay in relation to risk for testicular cancer among Finnish immigrants in Sweden. J Natl Cancer Inst 95:1238–1240PubMedCrossRef
12.
go back to reference Bray F, Richiardi L, Ekbom A et al (2006) Do testicular seminoma and nonseminoma share the same etiology? Evidence from an age-period-cohort analysis of incidence trends in eight European countries. Cancer Epidemiol Biomarkers Prev 15:652–658PubMedCrossRef Bray F, Richiardi L, Ekbom A et al (2006) Do testicular seminoma and nonseminoma share the same etiology? Evidence from an age-period-cohort analysis of incidence trends in eight European countries. Cancer Epidemiol Biomarkers Prev 15:652–658PubMedCrossRef
13.
go back to reference Bergstrom R, Adami HO, Mohner M et al (1996) Increase in testicular cancer incidence in six European countries: a birth cohort phenomenon. J Natl Cancer Inst 88:727–733PubMedCrossRef Bergstrom R, Adami HO, Mohner M et al (1996) Increase in testicular cancer incidence in six European countries: a birth cohort phenomenon. J Natl Cancer Inst 88:727–733PubMedCrossRef
14.
go back to reference Huyghe E, Matsuda T, Daudin M et al (2004) Fertility after testicular cancer treatments: results of a large multicenter study. Cancer 100:732–737PubMedCrossRef Huyghe E, Matsuda T, Daudin M et al (2004) Fertility after testicular cancer treatments: results of a large multicenter study. Cancer 100:732–737PubMedCrossRef
15.
go back to reference Viel JF (1994) [Poisson regression in epidemiology]. Rev Epidemiol Sante Publique 42:79–87PubMed Viel JF (1994) [Poisson regression in epidemiology]. Rev Epidemiol Sante Publique 42:79–87PubMed
16.
go back to reference Zheng T, Holford TR, Ma Z et al (1996) Continuing increase in incidence of germ-cell testis cancer in young adults: experience from Connecticut, USA, 1935–1992. Int J Cancer 65:723–729PubMedCrossRef Zheng T, Holford TR, Ma Z et al (1996) Continuing increase in incidence of germ-cell testis cancer in young adults: experience from Connecticut, USA, 1935–1992. Int J Cancer 65:723–729PubMedCrossRef
17.
go back to reference Clayton D, Schifflers E (1987) Models for temporal variation in cancer rates. I: Age-period and age-cohort models. Stat Med 6:449–467PubMedCrossRef Clayton D, Schifflers E (1987) Models for temporal variation in cancer rates. I: Age-period and age-cohort models. Stat Med 6:449–467PubMedCrossRef
18.
go back to reference Clayton D, Schifflers E (1987) Models for temporal variation in cancer rates. II: Age-period-cohort models. Stat Med 6:469–481PubMedCrossRef Clayton D, Schifflers E (1987) Models for temporal variation in cancer rates. II: Age-period-cohort models. Stat Med 6:469–481PubMedCrossRef
19.
go back to reference Bray F, Sankila R, Ferlay J, Parkin DM (2002) Estimates of cancer incidence and mortality in Europe in 1995. Eur J Cancer 38:99–166PubMedCrossRef Bray F, Sankila R, Ferlay J, Parkin DM (2002) Estimates of cancer incidence and mortality in Europe in 1995. Eur J Cancer 38:99–166PubMedCrossRef
20.
go back to reference Jacobsen R, Moller H, Thoresen SO et al (2006) Trends in testicular cancer incidence in the Nordic countries, focusing on the recent decrease in Denmark. Int J Androl 29:199–204PubMedCrossRef Jacobsen R, Moller H, Thoresen SO et al (2006) Trends in testicular cancer incidence in the Nordic countries, focusing on the recent decrease in Denmark. Int J Androl 29:199–204PubMedCrossRef
21.
go back to reference Levi F, La Vecchia C, Boyle P, Lucchini F, Negri E (2001) Western and eastern European trends in testicular cancer mortality. Lancet 357:1853–1854PubMedCrossRef Levi F, La Vecchia C, Boyle P, Lucchini F, Negri E (2001) Western and eastern European trends in testicular cancer mortality. Lancet 357:1853–1854PubMedCrossRef
22.
go back to reference Purdue MP, Devesa SS, Sigurdson AJ, McGlynn KA (2005) International patterns and trends in testis cancer incidence. Int J Cancer 115:822–827PubMedCrossRef Purdue MP, Devesa SS, Sigurdson AJ, McGlynn KA (2005) International patterns and trends in testis cancer incidence. Int J Cancer 115:822–827PubMedCrossRef
23.
go back to reference Huyghe E, Plante P, Thonneau PF (2006) Testicular cancer variations in time and space in Europe. Eur Urol 51:621–8PubMedCrossRef Huyghe E, Plante P, Thonneau PF (2006) Testicular cancer variations in time and space in Europe. Eur Urol 51:621–8PubMedCrossRef
24.
go back to reference Shah MN, Devesa SS, Zhu K, McGlynn KA (2007) Trends in testicular germ cell tumours by ethnic group in the United States. Int J Androl 30:206–214PubMedCrossRef Shah MN, Devesa SS, Zhu K, McGlynn KA (2007) Trends in testicular germ cell tumours by ethnic group in the United States. Int J Androl 30:206–214PubMedCrossRef
25.
go back to reference Bray F, Richiardi L, Ekbom A et al (2006) Etiologic conclusions from similar birth cohort effects. Cancer Epidemiol Biomarkers Prev 15:1752CrossRef Bray F, Richiardi L, Ekbom A et al (2006) Etiologic conclusions from similar birth cohort effects. Cancer Epidemiol Biomarkers Prev 15:1752CrossRef
26.
go back to reference Verhoeven R, Houterman S, Kiemeney B, Koldewijn E, Coebergh JW (2007) Testicular cancer: Marked birth cohort effects on incidence and a decline in mortality in southern Netherlands since 1970. Eur J Cancer. doi:10.1016/j.ejca.2007.08.022 Verhoeven R, Houterman S, Kiemeney B, Koldewijn E, Coebergh JW (2007) Testicular cancer: Marked birth cohort effects on incidence and a decline in mortality in southern Netherlands since 1970. Eur J Cancer. doi:10.​1016/​j.​ejca.​2007.​08.​022
27.
go back to reference Bray F, Ferlay J, Devesa SS, McGlynn KA, Moller H (2006) Interpreting the international trends in testicular seminoma and nonseminoma incidence. Nat Clin Pract Urol 3:532–543PubMedCrossRef Bray F, Ferlay J, Devesa SS, McGlynn KA, Moller H (2006) Interpreting the international trends in testicular seminoma and nonseminoma incidence. Nat Clin Pract Urol 3:532–543PubMedCrossRef
28.
go back to reference McKiernan JM, Goluboff ET, Liberson GL, Golden R, Fisch H (1999) Rising risk of testicular cancer by birth cohort in the United States from 1973 to 1995. J Urol 162:361–363PubMedCrossRef McKiernan JM, Goluboff ET, Liberson GL, Golden R, Fisch H (1999) Rising risk of testicular cancer by birth cohort in the United States from 1973 to 1995. J Urol 162:361–363PubMedCrossRef
29.
go back to reference Liu S, Wen SW, Mao Y, Mery L, Rouleau J (1999) Birth cohort effects underlying the increasing testicular cancer incidence in Canada. Can J Public Health 90:176–180PubMed Liu S, Wen SW, Mao Y, Mery L, Rouleau J (1999) Birth cohort effects underlying the increasing testicular cancer incidence in Canada. Can J Public Health 90:176–180PubMed
30.
go back to reference Moller H (1989) Decreased testicular cancer risk in men born in wartime. J Natl Cancer Inst 81:1668–1669PubMedCrossRef Moller H (1989) Decreased testicular cancer risk in men born in wartime. J Natl Cancer Inst 81:1668–1669PubMedCrossRef
31.
go back to reference Wanderas EH, Tretli S, Fossa SD (1995) Trends in incidence of testicular cancer in Norway 1955–1992. Eur J Cancer 31A:2044–2048PubMedCrossRef Wanderas EH, Tretli S, Fossa SD (1995) Trends in incidence of testicular cancer in Norway 1955–1992. Eur J Cancer 31A:2044–2048PubMedCrossRef
Metadata
Title
Doubling of testicular cancer incidence rate over the last 20 years in southern France
Authors
Marie Walschaerts
Eric Huyghe
Audrey Muller
Jean-Marc Bachaud
Louis Bujan
Patrick Thonneau
Publication date
01-03-2008
Publisher
Springer Netherlands
Published in
Cancer Causes & Control / Issue 2/2008
Print ISSN: 0957-5243
Electronic ISSN: 1573-7225
DOI
https://doi.org/10.1007/s10552-007-9081-x

Other articles of this Issue 2/2008

Cancer Causes & Control 2/2008 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine